Brief Reprinted from "The Gray Sheet," May 19, 2008
Medtronic unveils its latest line of wireless implantable cardiac devices at the Heart Rhythm Society annual scientific sessions May 14-17 in San Francisco. The first devices to launch on the new Vision 3D wireless device platform are four implantable cardioverter defibrillators (ICDs) and two cardiac resynchronization therapy defibrillators (CRT-Ds), FDA-approved in April and expected to be commercially available in the "coming months." Additional Vision 3D platform products, including pacemakers and bi-ventricular pacemakers, will follow, the company said. Vision 3D technologies include Complete Capture Management to capture data from the right atrium and both ventricles of the heart, and adjust stimulation to patient needs. Other available Vision 3D features include: Conexus wireless telemetry via the CareLink network; the PainFree shock reduction feature, including ATP (anti-tachycardia pacing) During Charging; MVP managed ventricular pacing to reduce unnecessary pacing; and OptiVol to measure fluid levels in the thoracic cavity. Vision 3D "creates synergies across the platform so there's a common foundation across all the devices," Medtronic explains.
Click here to start your 30-day free trial of "The Gray Sheet"
